These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21756283)

  • 1. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
    Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
    Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
    Braendvang M; Bakken V; Gundersen LL
    Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.
    Vicente E; Duchowicz PR; Ortiz Edel V; Monge A; Castro EA
    Chem Biol Drug Des; 2010 Jul; 76(1):59-69. PubMed ID: 20492446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.
    Braendvang M; Gundersen LL
    Bioorg Med Chem; 2007 Nov; 15(22):7144-65. PubMed ID: 17804243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
    Puratchikody A; Natarajan R; Jayapal M; Doble M
    Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Chloro-6-(2-furyl)-9-(4-methoxybenzyl)-9H-purine.
    Braendvang M; Gundersen LL
    Acta Crystallogr C; 2007 May; 63(Pt 5):o274-6. PubMed ID: 17478910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.
    Biava M; Porretta GC; Poce G; De Logu A; Meleddu R; De Rossi E; Manetti F; Botta M
    Eur J Med Chem; 2009 Nov; 44(11):4734-8. PubMed ID: 19595488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agents.
    Friggeri L; Ballante F; Ragno R; Musmuca I; De Vita D; Manetti F; Biava M; Scipione L; Di Santo R; Costi R; Feroci M; Tortorella S
    J Chem Inf Model; 2013 Jun; 53(6):1463-74. PubMed ID: 23617317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives.
    Das SK; Panda G; Chaturvedi V; Manju YS; Gaikwad AK; Sinha S
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5586-9. PubMed ID: 17764933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
    Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitubercular potential of plants: a brief account of some important molecules.
    Negi AS; Kumar JK; Luqman S; Saikia D; Khanuja SP
    Med Res Rev; 2010 Jul; 30(4):603-45. PubMed ID: 19626592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOC chemistry for tuberculosis-further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives.
    Pieroni M; Lilienkampf A; Wang Y; Wan B; Cho S; Franzblau SG; Kozikowski AP
    ChemMedChem; 2010 Oct; 5(10):1667-72. PubMed ID: 20718072
    [No Abstract]   [Full Text] [Related]  

  • 17. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
    Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
    Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
    Pasqualoto KF; Ferreira EI; Santos-Filho OA; Hopfinger AJ
    J Med Chem; 2004 Jul; 47(15):3755-64. PubMed ID: 15239654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective anti-tubercular purines: synthesis and chemotherapeutic properties of 6-aryl- and 6-heteroaryl-9-benzylpurines.
    Braendvang M; Gundersen LL
    Bioorg Med Chem; 2005 Dec; 13(23):6360-73. PubMed ID: 16081292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.